Brief: Shield Therapeutics Provides Business Update And U.S. Q2 2023 Highlights
20/07/2023 07:48
July 20 (Reuters) - Shield Therapeutics PLC STXS.L :
* SHIELD THERAPEUTICS - BUSINESS UPDATE AND U.S. Q2 2023
HIGHLIGHTS
Source text for Eikon: ID:nRST5804Ga
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update